Effective treatment with daratumumab in post-HSCT refractory immune-mediated cytopenias: a case report and literature review
Immune-mediated cytopenias (IMCs) following allogeneic hematopoietic stem cell transplantation (HSCT) can lead to substantial morbidity and mortality, presenting a major therapeutic obstacle. Here, we report a case of a pediatric patient with acquired …